Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up since Aug 25 · below the Ichimoku cloud · RSI 48 · MACD above its signal
None of the 29 investors followed here reported a position in RMSL in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a RMSL trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 309.4 | 6.2 | -11.4 | -31.3 | -51.1 | 20.0 | -39.4 | 19.4 | -21.5 | 0.0 | −11.8% | ||
| 2025 | 63.9 | -17.6 | -10.7 | -10.0 | -23.3 | 42.0 | -32.1 | -36.8 | -45.7 | 27.2 | -13.8 | -32.0 | −79.5% |
| 2024 | -39.4 | -20.2 | 65.9 | -20.4 | 61.6 | -4.5 | -39.8 | -5.4 | 4.1 | -22.7 | 11.4 | 6.4 | −46.5% |
| 2023 | 37.2 | -5.8 | -19.8 | -0.4 | -4.7 | -6.5 | 3.5 | 51.3 | -16.7 | -7.7 | 19.1 | -6.1 | +24.0% |
| 2022 | 59.7 | -34.8 | 2.2 | 46.4 | 103.9 | -43.5 | 0.0 | -35.2 | -17.0 | 8.7 | -7.2 | -2.3 | −4.9% |
| 2021 | 7.5 | 137.2 | -11.8 | 166.7 | -18.7 | -49.7 | 6.1 | 13.5 | 86.4 | -35.5 | 5.4 | -12.0 | +228.7% |
| 2020 | -23.1 | -8.0 | -25.0 | 1.4 | -37.1 | 2.3 | 28.9 | -13.3 | -20.5 | -27.5 | -44.8 | 150.0 | −69.2% |
| 2019 | -8.3 | -34.5 | -31.9 | -14.3 | 171.4 | -24.1 | -14.5 | -5.4 | -51.4 | -30.0 | 12.6 | -3.0 | −78.3% |
| 2018 | 0.0 | 0.0 | 300.0 | -63.6 | 55.0 | -44.4 | -44.9 | -63.2 | -46.4 | -46.7 | 0.0 | 50.0 | −89.1% |
| 2017 | 1100.0 | 0.0 | 0.0 | -40.0 | 0.0 | 386.1 | -97.1 | -25.0 | 0.0 | 13.3 | 0.0 | -35.3 | −45.0% |
| 2016 | 0.0 | -66.7 | 200.0 | 0.0 | 0.0 | 233.3 | 0.0 | 50.0 | 0.0 | -60.0 | 0.0 | -16.7 | +66.7% |
| 2015 | 0.0 | 33.3 | -36.3 | 9.8 | -73.2 | 6.7 | 12.5 | -5.6 | 17.6 | 0.0 | 0.0 | -85.0 | −95.0% |
| 2014 | -25.0 | 50.0 | -33.3 | -33.3 | -25.0 | 16.7 | 0.0 | -14.3 | -16.7 | -20.0 | 0.0 | -25.0 | −81.3% |
| 2013 | -14.3 | 13.3 | -92.6 | -22.0 | -12.8 | 8.8 | -10.8 | -33.3 | 0.0 | 0.0 | -36.4 | 14.3 | −97.7% |
| 2012 | -72.5 | 114.3 | 0.0 | -66.7 | 0.0 | -71.0 | 244.8 | 0.0 | -6.0 | -36.2 | 16.7 | 0.0 | −86.3% |
| 2011 | -56.3 | -23.8 | -6.3 | 0.7 | -20.5 | 0.0 | -33.3 | 62.5 | 53.8 | 0.0 | -40.0 | 325.0 | +6.3% |
| 2010 | -36.7 | 5.3 | 25.0 | -60.0 | 600.0 | -21.4 | -7.3 | -2.0 | 48.0 | -29.1 | -8.6 | 0.0 | +60.0% |
| 2009 | 0.0 | 0.0 | -4.8 | -5.0 | 57.9 | +42.9% |
No insider transactions reported for RMSL.
No analyst coverage for this instrument.
REMSleep Holdings, Inc., focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves durable medical equipment providers, hospital and acute care facilities, sleep labs, physicians, sleep and neurology, and medical associations. The company is headquartered in Blackshear, Georgia.
No recent headlines.